BBH
BBH
About VanEck Biotech ETF
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
About VanEck Biotech ETF
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 AMGN | Amgen Inc. | 15.09% | 166.57K | $60.04M |
 GILD | Gilead Sciences, Inc. | 13.22% | 400.34K | $52.60M |
 VRTX | Vertex Pharmaceuticals Incorporated | 8.75% | 72.48K | $34.81M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.56% | 39.39K | $26.12M |
 RVMD | Revolution Medicines, Inc. | 5.15% | 111.38K | $20.49M |
 NTRA | Natera, Inc. | 4.92% | 71.68K | $19.56M |
 ARGX | argenx SE | 4.67% | 21.20K | $18.57M |
 IQV | IQVIA Holdings Inc. | 4.60% | 88.16K | $18.30M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.65% | 50.36K | $14.51M |
 BIIB | Biogen Inc. | 3.49% | 66.39K | $13.88M |
 ILMN | Illumina, Inc. | 3.41% | 71.33K | $13.56M |
 MRNA | Moderna, Inc. | 3.20% | 189.95K | $12.73M |
 ONC | BeOne Medicines AG | 2.98% | 39.00K | $11.85M |
 UTHR | United Therapeutics Corporation | 2.78% | 20.63K | $11.05M |
 INSM | Insmed Incorporated | 2.72% | 99.05K | $10.81M |
 INCY | Incyte Corporation | 2.50% | 86.95K | $9.93M |
 NBIX | Neurocrine Biosciences, Inc. | 2.14% | 48.87K | $8.51M |
 BNTX | BioNTech SE | 1.87% | 82.54K | $7.43M |
 ICLR | ICON Public Limited Company | 1.81% | 43.32K | $7.20M |
 TECH | Bio-Techne Corporation | 1.55% | 86.31K | $6.16M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Switzerland
Germany
IrelandSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Switzerland Germany IrelandHoldings (Top 20)
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
RVMD
Revolution Medicines, Inc.
NTRA
Natera, Inc.
ARGX
argenx SE
IQV
IQVIA Holdings Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
BIIB
Biogen Inc.
ILMN
Illumina, Inc.
MRNA
Moderna, Inc.
ONC
BeOne Medicines AG
UTHR
United Therapeutics Corporation
INSM
Insmed Incorporated
INCY
Incyte Corporation
NBIX
Neurocrine Biosciences, Inc.
BNTX
BioNTech SE
ICLR
ICON Public Limited Company
TECH
Bio-Techne Corporation